<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7253763\results\search\disease\results.xml">
  <result pre="the original work is properly cited.S0899823X20002469a.pdfref-count: page-count: To the Editorâ€&quot;Coronavirus" exact="disease" post="2019 (COVID-19) is currently in the spotlight, attracting all"/>
  <result pre="of the pandemic, and under the pressure caused by the" exact="absence of" post="specific antivirals and vaccines, antimicrobials are being used in"/>
  <result pre="are being used as empirical coverage for possible coexisting community-acquired" exact="infection" post="of the respiratory tract, especially in severe cases of"/>
  <result pre="as empirical coverage for possible coexisting community-acquired infection of the" exact="respiratory" post="tract, especially in severe cases of COVID-19. They are"/>
  <result pre="used as empirical coverage for possible hospital-acquired superinfection of the" exact="respiratory" post="tract, taking into account that a significant proportion of"/>
  <result pre="being prescribed for the targeted treatment of community or hospital-acquired" exact="respiratory" post="tract co- or superinfections. Finally, antimicrobials are being used"/>
  <result pre="empirical or targeted treatment for co- or superinfection outside the" exact="respiratory" post="tract. However, several issues regarding the aforementioned uses of"/>
  <result pre="to support or reject this approach. Second, most data regarding" exact="bacterial" post="and fungal respiratory co- and superinfections in the context"/>
  <result pre="reject this approach. Second, most data regarding bacterial and fungal" exact="respiratory" post="co- and superinfections in the context of a viral"/>
  <result pre="fungal respiratory co- and superinfections in the context of a" exact="viral" post="respiratory pandemic are derived from previous influenza pandemics,4 and"/>
  <result pre="respiratory co- and superinfections in the context of a viral" exact="respiratory" post="pandemic are derived from previous influenza pandemics,4 and data"/>
  <result pre="data from previous coronavirus epidemics are limited.5â€&quot;7 In any case," exact="bacterial" post="and fungal respiratory co- and superinfections during large outbreaks"/>
  <result pre="coronavirus epidemics are limited.5â€&quot;7 In any case, bacterial and fungal" exact="respiratory" post="co- and superinfections during large outbreaks of viral respiratory"/>
  <result pre="and fungal respiratory co- and superinfections during large outbreaks of" exact="viral" post="respiratory illnesses are probably underdiagnosed due to a shortage"/>
  <result pre="fungal respiratory co- and superinfections during large outbreaks of viral" exact="respiratory" post="illnesses are probably underdiagnosed due to a shortage of"/>
  <result pre="due to a shortage of trained healthcare personnel and/or supplies," exact="infection" post="control requirements, high workload, and the emergent nature of"/>
  <result pre="control requirements, high workload, and the emergent nature of the" exact="primary" post="viral disease that make the diagnosis complex and laborious."/>
  <result pre="requirements, high workload, and the emergent nature of the primary" exact="viral" post="disease that make the diagnosis complex and laborious. Data"/>
  <result pre="high workload, and the emergent nature of the primary viral" exact="disease" post="that make the diagnosis complex and laborious. Data from"/>
  <result pre="accordance with previous coronavirus epidemics, show that the rate of" exact="bacterial" post="and fungal co- or superinfection is relative low, but"/>
  <result pre="broad-spectrum antimicrobials is very common.1 Specifically, in the current literature," exact="bacterial" post="and fungal co- and superinfections have been reported in"/>
  <result pre="antimicrobial treatment must be always guided by the source of" exact="infection" post="acquisition, local patterns of antimicrobial resistance, host factors, and"/>
  <result pre="or loop-mediated isothermal amplification assay) are highly important in diagnosing" exact="bacterial" post="and fungal co- and superinfections or other viral infections"/>
  <result pre="in diagnosing bacterial and fungal co- and superinfections or other" exact="viral" post="infections during the course of COVID-19. They must be"/>
  <result pre="diagnosing bacterial and fungal co- and superinfections or other viral" exact="infections" post="during the course of COVID-19. They must be used"/>
  <result pre="levels may occur in advanced stages of COVID-19 without proven" exact="bacterial" post="co- or superinfection.9 C-reactive protein is elevated in most"/>
  <result pre="is elevated in most COVID-19 cases, and it cannot predict" exact="bacterial" post="or fungal co- or superinfection.10 Chest computed-tomography may reveal"/>
  <result pre="that is, solely ground-glass opacities, which are not common in" exact="bacterial pneumonia;" post="therefore, such findings can help avoid antimicrobial use. We"/>
  <result pre="Al-HameedF, et al.Macrolides in critically ill patients with Middle East" exact="respiratory" post="syndrome. Int J Infect Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH,"/>
  <result pre="Int J Infect Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH, JiangJS, KaoSJ." exact="Severe" post="acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics"/>
  <result pre="J Infect Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH, JiangJS, KaoSJ. Severe" exact="acute" post="respiratory syndrome in Taiwan: analysis of epidemiological characteristics in"/>
  <result pre="Infect Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH, JiangJS, KaoSJ. Severe acute" exact="respiratory" post="syndrome in Taiwan: analysis of epidemiological characteristics in 29"/>
  <result pre="Dis2019;81:184â€&quot;190.30690213 6.JangTN, YehDY, ShenSH, HuangCH, JiangJS, KaoSJ. Severe acute respiratory" exact="syndrome" post="in Taiwan: analysis of epidemiological characteristics in 29 cases."/>
  <result pre="change in pathogen pattern associated with an outbreak of severe" exact="acute" post="respiratory syndrome. Clin Infect Dis2004;39:511â€&quot;516.15356814 8.MercuroNJ, YenCF, ShimDJ, et"/>
  <result pre="in pathogen pattern associated with an outbreak of severe acute" exact="respiratory" post="syndrome. Clin Infect Dis2004;39:511â€&quot;516.15356814 8.MercuroNJ, YenCF, ShimDJ, et al.Risk"/>
  <result pre="without concomitant azithromycin among hospitalized patients testing positive for coronavirus" exact="disease" post="2019 (COVID-19). JAMA Cardiol2020. doi: 10.1001/jamacardio.2020.1834. 9.LippiG, PlebaniM. Procalcitonin"/>
  <result pre="doi: 10.1001/jamacardio.2020.1834. 9.LippiG, PlebaniM. Procalcitonin in patients with severe coronavirus" exact="disease" post="2019 (COVID-19): a meta-analysis. Clin Chim Acta2020;505:190â€&quot;191.32145275 10.LiL, HuangQ,"/>
  <result pre="a meta-analysis. Clin Chim Acta2020;505:190â€&quot;191.32145275 10.LiL, HuangQ, WangDC, IngbarDH, WangX." exact="Acute" post="lung injury in patients with COVID-19 infection. Clin Translat"/>
 </snippets>
</snippetsTree>
